Matthew Labriola

11PUBLICATIONS

86CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSocial and community informaticsInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jul 10, 2026

Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

|May 28, 2026

EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Aug 23, 2024

DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes.

Laura S Graham, Nicholas C Henderson, Olesia Kellezi

|Jul 17, 2024

Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer.

Amanda Broderick, Elizabeth Pan, Jinju Li

|Apr 05, 2024

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.

Joseph J Park, Alec Chu, Jinju Li

|Feb 22, 2024

Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.

Zeynep B Zengin, Nicholas C Henderson, Joseph J Park

Pageof 2

Frequent Collaborators

6 joint publications

Andrew J Armstrong

5 joint publications

Michael Thomas Schweizer

Clara Hwang

Tanya Dorff

Rana R McKay

Laura S Graham

Rohan Garje

Pedro C Barata

Daniel J George

Vadim S Koshkin

Frequent Collaborators

6 joint publications

Andrew J Armstrong

5 joint publications

Michael Thomas Schweizer

5 joint publications

Clara Hwang

5 joint publications

Tanya Dorff